Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Annexon Inc stock

Learn how to easily invest in Annexon Inc stock.

Annexon Inc is a biotechnology business based in the US. Annexon Inc shares (ANNX) are listed on the NASDAQ and all prices are listed in US Dollars. Annexon Inc employs 75 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Annexon Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ANNX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Annexon Inc stock price (NASDAQ: ANNX)

Use our graph to track the performance of ANNX stocks over time.

Annexon Inc shares at a glance

Information last updated 2022-10-02.
Latest market close$6.28
52-week range$2.06 - $22.34
50-day moving average $5.67
200-day moving average $5.33
Wall St. target price$18.71
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.64

Buy Annexon Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Annexon Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Annexon Inc price performance over time

Historical closes compared with the close of $6.28 from 2022-10-03

1 week (2022-09-27) 2.45%
1 month (2022-08-31) N/A
3 months (2022-07-01) 61.44%
6 months (2022-03-31) N/A
1 year (2021-10-04) -66.74%
2 years (2020-10-02) -76.71%
3 years (2019-09-30) N/A
5 years (2017-09-30) N/A

Annexon Inc financials

Gross profit TTM $0
Return on assets TTM -33.03%
Return on equity TTM -62.79%
Profit margin 0%
Book value $4.35
Market capitalisation $294.3 million

TTM: trailing 12 months

Annexon Inc share dividends

We're not expecting Annexon Inc to pay a dividend over the next 12 months.

Annexon Inc share price volatility

Over the last 12 months, Annexon Inc's shares have ranged in value from as little as $2.06 up to $22.335. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Annexon Inc's is 0.4784. This would suggest that Annexon Inc's shares are less volatile than average (for this exchange).

Annexon Inc overview

Annexon, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis. The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.

Frequently asked questions

What percentage of Annexon Inc is owned by insiders or institutions?
Currently 2.386% of Annexon Inc shares are held by insiders and 92.359% by institutions.
How many people work for Annexon Inc?
Latest data suggests 75 work at Annexon Inc.
When does the fiscal year end for Annexon Inc?
Annexon Inc's fiscal year ends in December.
Where is Annexon Inc based?
Annexon Inc's address is: 1400 Sierra Point Parkway, Brisbane, CA, United States, 94005
What is Annexon Inc's ISIN number?
Annexon Inc's international securities identification number is: US03589W1027

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site